Apidra is the brand name for insulin glulisine, a rapid-acting insulin used to control blood sugar in diabetes. If you’re looking at a vial, here are the basics:
- Concentration and amount: typically 100 units per mL. A common vial is 10 mL, which contains 1000 units total.
- Appearance: clear, colorless solution.
- Storage:
- Unopened vials: refrigerate at 2–8°C (36–46°F) until first use.
- After opening: store at room temperature (about 15–30°C) and use within 28 days. Do not refrigerate after opening if that would make it uncomfortable to inject; avoid heat or direct sunlight.
- Do not freeze.
- Administration (general): inject subcutaneously, usually within 15 minutes before meals or within 20 minutes after starting a meal, as prescribed. Common injection sites are the abdomen, thigh, or upper arm. Rotate injection sites.
- Dosing: individualized based on your needs, meal plan, and blood sugar targets. Do not adjust dose without your clinician’s guidance.
- Mixing: in some regimens, Apidra can be mixed in the same syringe with NPH insulin, but it should not be mixed with long-acting insulins like insulin glargine (Lantus) or insulin detemir. Follow your clinician’s instructions.
- Safety: do not share needles or pens. Check for any particles or cloudiness (it should be clear). If you notice bubbles, unusual color, or changes, contact your healthcare provider.
- When to seek help: signs of hypoglycemia (shaking, sweating, confusion) or hyperglycemia (very high blood sugar), allergic reactions, or if you have any concerns about dosing.
If you meant a different Apidra product (for example, a KwikPen or SoloStar prefilled pen) or you have a specific question (storage, dosing, or how to use it), tell me and I’ll tailor the answer.